New IARC and WHO study estimates how reducing mortality from NCDs could affect longevity

12/11/2018 A new study by scientists from the International Agency for Research on Cancer (IARC) and the World Health Organization (WHO) estimates how reducing premature mortality from either all noncommunicable diseases (NCDs) or the four major NCDs would affect progress towards achieving United Nations Sustainable Development Goal 3: “Ensure healthy lives and promote well-being for all at all ages”. Goal 3 calls for a reduction of premature mortality from NCDs by one third by 2030 through prevention and treatment and by promoting mental health and well-being. The feasibility of reducing mortality to the targeted level within 15 years was also assessed on the basis of historical mortality trends in 2000–2015.

Cao B, Bray F, Ilbawi A, Soerjomataram I
Effect on longevity of one-third reduction in premature mortality from non-communicable diseases by 2030: a global analysis of the Sustainable Development Goal health target
Lancet Global Health, Published online 9 November 2018;
Read article, More on the Sustainable Development Goals

IARC Monographs evaluation of the carcinogenicity of some nitrobenzenes and other industrial chemicals

02/11/2018 The results of the recent IARC Monographs evaluation of the carcinogenicity of some nitrobenzenes (2-chloronitrobenzene, 4-chloronitrobenzene, 1,4-dichloro-2-nitrobenzene, 2,4-dichloro-1-nitrobenzene, and para-nitroanisole) and other industrial chemicals (2-amino-4-chlorophenol, ortho-phenylenediamine, ortho-phenylenediamine dihydrochloride, and N,N-dimethylacetamide) have now been published in The Lancet Oncology.This summary article presents the conclusions of the IARC Monographs Meeting 123. The evaluations for 2-chloronitrobenzene and 4-chloronitrobenzene were updated since these agents were considered previously in 1995. The remaining agents were evaluated by the Working Group for the first time.
The full scientific assessments will be published as Volume 123 of the IARC Monographs.

IARC Monographs Vol. 123 Group
Lancet Oncol, Published online 2 November 2018;
Read more

IARC and ISBER sign Memorandum of Agreement

30/10/2018 The International Agency for Research on Cancer (IARC) and the International Society for Biological and Environmental Repositories (ISBER) have signed a Memorandum of Agreement to support the development of biobanking activities in low- and middle-income countries (LMICs). The agreement will lead to greater collaboration in strengthening the IARC-led LMICs Biobank and Cohort Building Network (BCNet), which focuses on improving biobanking infrastructure and practices in LMICs. In addition, IARC and ISBER will collaborate on the creation of a joint working group for the development of educational activities for clinical biobanking in LMICs. More information about ISBER , More information about BCNet

IARC Director’s presentation at World Cancer Leaders’ Summit

23/10/2018 Dr Christopher P. Wild, Director of the International Agency for Research on Cancer (IARC), gave a closing address at the recent World Cancer Leaders’ Summit, held in Kuala Lumpur, Malaysia. In his presentation titled “Reducing the global cancer burden: failure is success in progress”, Dr Wild made 10 key observations about the current status of cancer control globally. These included the scale, inequalities, and cost of cancer, the need to prioritize prevention, and a call for more engagement from scientists in formulating evidence-based policies. He also highlighted the current disconnect between political awareness on cancer and the levels of investment via development assistance for health. View slides from presentation , View summary of Summit


WHO Classification of Skin Tumours

10/09/2018 The WHO Classification of Skin Tumours is the 11th volume in the 4th edition of the WHO series on the classification of human tumours. These authoritative and concise reference books provide an international standard for anyone involved in cancer research or the care of cancer patients.

This book has been prepared by 183 contributors from 24 countries. It contains more than 900 colour images and tables, and more than 2900 references.
Read more

Cancer Today


Cancer Today is part of the Global Cancer Observatory website.